The update covers some areas of MIFID investor protection that are relevant to structured product manufacturers.
We found Q.22 and Q.23 particularly interesting because they clarify the position on generic or one-off disclosures and the use of ranges to meet ex-ante cost and charges disclosure requirements. Another one to highlight is Q.25, which is consistent with the ongoing European regulatory theme of ensuring comparability for investors across product providers by harmonising terminology – something we’ve invested a lot of our own time in over the past three years!
Click here to read the full report.
Please contact us if you would like to find out how we can help you manage your programme and prospectus updates efficiently with respect to the prospectus regulation.